CPT code 93289 covers face-to-face evaluation and optimal reprogramming of an implanted single-, dual-, or multi-lead implantable cardioverter-defibrillator (ICD), including both professional and technical components. This service is critical for managing device function, preventing inappropriate shocks, and tailoring therapy to changes in cardiac rhythm or clinical status. Nationally, ICD reprogramming is a key component of long-term device management and impacts patient safety, device longevity, and downstream utilization.

Primary payers relevant to this code include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The analysis accompanying this summary addresses how coverage and billing practices for 93289 align across major commercial payers and Medicare, and highlights common clinical scenarios warranting in-person device reprogramming.

Readers will find benchmarks for typical use and site-of-service patterns, an overview of payer coverage considerations, and the clinical context for when face-to-face reprogramming is indicated. The content also outlines coding scope—this code represents both professional and technical work—and typical settings where the service is delivered, such as hospital outpatient departments, electrophysiology labs, and clinic procedure rooms. Data not provided in the input are noted as unavailable where relevant.